When integrated into your EMR, Lexicomp's drug reference content and drug interaction data will help you achieve the clinical decision support component of Meaningful Use.
Let’s face it: your customers need to prove Meaningful Use of their certified EMR in order to qualify to receive government incentive money. And if you don’t clearly communicate to users how your system will help them achieve Meaningful Use, you may get left behind.
So rest assured that when you implement Lexicomp's drug data and reference information, your EMR will be one step closer to complying with Meaningful Use! Lexicomp provides:
- Data for drug-drug, drug-allergy and drug-disease interaction screening
- Data to support duplicate therapy and dose range checking for pediatric and adult patients
- Data that allows users to generate patient-specific education handouts
For more information, go to
www.lexi.com/meaningful-use.
When integrated into your EMR, Lexicomp's drug reference content and drug interaction data will help you achieve the clinical decision support component of Meaningful Use.
Let’s face it: your customers need to prove Meaningful Use of their certified EMR in order to qualify to receive government incentive money. And if you don’t clearly communicate to users how your system will help them achieve Meaningful Use, you may get left behind.
So rest assured that when you implement Lexicomp's drug data and reference information, your EMR will be one step closer to complying with Meaningful Use! Lexicomp provides:
- Data for drug-drug, drug-allergy and drug-disease interaction screening
- Data to support duplicate therapy and dose range checking for pediatric and adult patients
- Data that allows users to generate patient-specific education handouts
For more information, go to
www.lexi.com/meaningful-use or stop by the Lexicomp booth #6653 at HIMSS!
When integrated into your EMR, Lexicomp's drug reference content and drug interaction data will help you achieve the clinical decision support component of Meaningful Use.
Let’s face it. Your customers need to prove Meaningful Use of their certified EMR in order to qualify to receive government incentive money. And if you don’t clearly communicate to users how your system will help them achieve Meaningful Use, you may get left behind.
So rest assured that when you implement Lexicomp's drug data and reference information, your EMR will be one step closer to complying with Meaningful Use! Lexicomp provides:
- Data for drug-drug, drug-allergy and drug-disease interaction screening
- Data to support duplicate therapy and dose range checking for pediatric and adult patients
- Data that allows users to generate patient-specific education handouts
For more information, go to
www.lexi.com/meaningful-use
Does your system comply with Meaningful Use?
When integrated into your EMR, our drug reference content and drug interaction data will help you achieve the clinical decision support component of Meaningful Use.
Let’s face it. Your customers need to prove Meaningful Use of their certified EMR in order to qualify to receive government incentive money. And if you don’t clearly communicate to users how your system will help them achieve Meaningful Use, you may get left behind.
So rest assured that when you implement Lexi-Comp’s drug data and reference information, your EMR will be one step closer to complying with Meaningful Use! Lexi-Comp provides:
- Data for drug-drug, drug-allergy and drug-disease interaction screening
- Data to support duplicate therapy and dose range checking for pediatric and adult patients
- Data that allows users to generate patient-specific education handouts
New in November 2010! Lexi-Comp can help your EMR meet ONC’s “Submission to Immunization Registries” standard!
We’ll provide you immunization-specific data (CVX and MVX codes) that enables healthcare providers and end users to electronically transmit a patient’s vaccination history to an official registry.
For more information, go to
www.lexi.com/meaningful-use
Now more than ever, it's vital your EMR contains the drug data necessary to help customers achieve Meaningful Use of EHR. In fact, in a recent study conducted by
CSC, 90 percent of hospital executives said meeting Meaningful Use guidelines was one of their top priorities.
The numbers speak for themselves. Your customers are on the fast track to prove Meaningful Use of EHR. And if you don't clearly communicate to users how your system will help meet Meaningful Use guidelines, you may get left behind.
Lexi-Comp's transactional data and reference solutions can help your system comply with the final rule on Meaningful Use by helping you support the technical capabilities required for certification of your system. Specifically, Lexi-Comp can provide your EMR the core drug data and reference information you need to achieve the clinical decision support component of Meaningful Use. When integrated into your system, Lexi-Comp will:
- Provide data for drug-drug, drug-disease and drug-allergy interaction screening
- Provide duplicate therapy and dose range checking for pediatric and adult patients
- Provide a drug list of dispensable products with mapping to NDC numbers, RXCUI, Lexi-Comp's Global ID, Multum DNUM and generic product codes
- Support the maintenance of active medication and allergy lists within an EMR
- Promote interoperability
- Allow users to generate patient-specific education leaflets
For more information on how Lexi-Comp can help your EMR meet Meaningful Use Stage 1 criteria, visit
www.lexi.com/meaningful-use/
Lexi-Comp's transactional drug data and reference solutions can help your EMR comply with the final rule on Meaningful Use by helping you support the technical capabilities required for certification of your system. Specifically, we can provide your EMR the core drug data and reference information you need to achieve the clinical decision support component of Meaningful Use. When integrated into your system, Lexi-Comp will:
- Provide data for drug-drug, drug-disease and drug-allergy interaction screening
- Provide duplicate therapy and dose range checking for pediatric and adult patients
- Provide a drug list of dispensable products with mapping to NDC numbers, RXCUI, Lexi-Comp’s Global ID, and Multum DNUM and generic product codes
- Support the maintenance of active medication and allergy lists within an EMR
- Promote interoperability
- Allow users to generate patient-specific education leaflets
According to a new survey by research company Knowledge Networks, the increasing adoption of EHRs and other digital technologies by primary care physicians and specialists points to trends expected to create "dramatic upswings in doctors' case loads." The survey of nearly 11,000 healthcare professionals was conducted using Mt. Arlington, N.J.-based Physicians Consulting Network (PCN), a physician panel of specialists and other healthcare professionals.
According to the survey, 52% of specialists and and 50% of PCPs are already keeping their patient records in an electronic format - up 10 percentage points for specialists and 12 points for PCPs since 2008. These "early adopter" levels suggest a desire for digital convenience at a time when patient record keeping promises to become exponentially more complex.
Did you know that Lexi-Comp provides clinical decision support data needed for patient specific alerts (i.e., drug interactions, drug, allergy checking, duplicate therapy, and dose range checking)? With meaningful use of EHR a top priority and patient records becoming more complex, the race is on to get your EHR to market.
In a recent article published in
Healthcare IT News, The Centers for Medicare and Medicaid Services will begin to make Meaningful Use incentive payments to eligible physicians and hospitals as early as May, 2011.
"CMS will open registration for the incentive program in January," said senior CMS official Karen Trudel. "To begin receiving payments, healthcare providers must verify that they have demonstrated meaningful use of certified electronic health records for 90 days," she added.
Hospitals were first tasked with the burden of sifting through over 800 pages of Meaningful Use requirements. Next, they were faced with the additional barriers that accompany implementing and satisfying the requirements of clinical decision support tools such as CPOE, Drug Interaction Checking, Dose Rang Checking and Duplicate Therapy. The bar is high...but the reward is great.
Getting it right is important because CMS will pay out billions of dollars in incentives called for in the HITECH Act over the next several years. Trudel goes on to explain, "The pressure is on...We are now working toward making all of this a reality and we have only about six months to do it."
Meanwhile, the Office of the National Coordinator (ONC) is establishing a temporary electronic health record certification program and hopes to have multiple organizations ready to certify EHR products, including clinical decision support tools, to eliminate "bottlenecks" in the process.
Healthcare providers do not have to inform CMS what certified EHR system they are using until they submit information verifying they have met meaningful use requirements.
Let's face it. With billions of dollars on the line, meaningful use will drive hospitals to the next generation of healthcare. And that's the reality.
Federal officials released the long-awaited final rule on Meaningful Use Tuesday, July 14. In an article published in Healthcare IT News, initial response was "cautiously optimistic," but the American Hospital Association expressed concerns. Although initially pleased with the "added flexibility and removal of some unnecessary administrative burdens," the AHA leaders said they remain concerned that the requirements "may be out of reach for many hospitals."
AHA Concerns include:- Individual hospitals in multi-campus settings are unfairly excluded from incentive payments;
- The rule may adversely impact rural hospitals and exacerbate the digital divide in healthcare;
- The rule requires hospitals to immediately use Computerized Physician Order Entry (CPOE), "which can be complicated, costly to implement and take time to do right;"
- The rule, in combination with the CCHIT certification process, "penalizes early adopters" by requiring them to upgrade or replace already functional systems;
- The rule limits how quickly hospitals can adopt a certified EHR vendor that can benefit patient care
Hospitals are first tasked with the burden of sifting through the over 800 pages of Meaningful Use requirements. Then, they are faced with the additional barriers that accompany implementing and satisfying these requirements with clinical decision support tools such as CPOE, Drug Interaction Checking, Dose Rang Checking and Duplicate Therapy.
The AHA concluded that, "Unfortunately, the CMS continues to to place some barriers in the way of achieving widespread IT adoption."
Powered by Compendium